TenNor Therapeutics
Westfield
About TenNor Therapeutics
TenNor Therapeutics is a clinical stage, product development company with a sharp focus on unmet medical needs in the area of infectious diseases. The company possesses a dual-acting drug discovery platform with several innovative products in various stages of preclinical and clinical development. The company is developing new drugs for the treatment of Helicobacter pylori infections, prosthetic joint infections, multidrug-resistant Gram-negative infections and some other common and serious infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $118.2M
- Funding stage: Late Stage Venture
- Last round: Series E (Oct 2024)
- Website: tennorx.com
- Phone: 9082330951
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tennor-therapeutics-62173 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.